Harvard Bioscience, Inc.
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving Harvard Bioscience, Inc. now
Current reporting with the operating signal separated from the noise.
Harvard Bioscience, Inc. (HBIO) Q1 2026 Earnings Call Transcript
Investors are testing whether Harvard Bioscience, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Harvard Bioscience, Inc. (NASDAQ:HBIO) Q4 2025 Earnings Call Transcript
Investors are testing whether Harvard Bioscience, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Harvard Bioscience, Inc. to Present and Host One-on-One Meetings at the 14th Annual East Coast IDEAS Conference on June 12, 2024
The story matters when it changes Harvard Bioscience, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Harvard Bioscience, Inc. to Present at the Jefferies Global Healthcare Conference on June 5, 2024
The story matters when it changes Harvard Bioscience, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Latest HBIO filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
Harvard Bioscience, Inc., quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
SEARCH Q1 COVERAGE →Second quarter
No verified period-specific item in the current feed.
SEARCH Q2 COVERAGE →Third quarter
No verified period-specific item in the current feed.
SEARCH Q3 COVERAGE →